Disc Medicine, Inc. (IRON)
74.92
+0.92
(+1.25%)
USD |
NASDAQ |
Jan 21, 16:00
74.92
0.00 (0.00%)
After-Hours: 18:05
Disc Medicine Research and Development Expense (Annual): 96.52M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 10.99B |
| Boston Scientific Corp. | 1.615B |
| Penumbra, Inc. | 94.78M |
| Emergent BioSolutions, Inc. | 64.90M |
| Revolution Medicines, Inc. | 584.60M |